Program objectives: • Compare and contrast currently available GLP-1 RAs in Canada. • Reflect on how to optimize T2D management using the GLP-1 RA class. • Discuss practical elements for initiating GLP-1 RA therapy. Presenter: Dr. Netee Papneja

Primary Learning Objectives / Topics:

1. Review the impact of tobacco on diabetes development
2. Examine the impact of tobacco on morbidity and mortality
3. Discuss the importance of vascular protection in patients with type 2 diabetes
4. Review the role of pharmacotherapy in smoking cessation
5. Apply cessation counselling to different patient cases

Speaker

Michael Boivin, RPh
Clinical Pharmacist Consultant
CommPharm Consulting Inc.

Date

20 Sept. 2018

Registration

6:30 pm

Location

Michelangelo Events & Conference Centre
1555 Upper Ottawa Street

Download the invitiation

Join HDPhA for their 2018 Annual General Meeting and a presentation on Probiotics and the Gut Microbiome by Dr. Malisa Carullo, ND.

AGM: 6 pm

Download invitation

GSK is pleased to offer a session delivered by GSK Medical on INCRUSE ELLIPTA and BREO ELLIPTA 100/25 mcg, two COPD medications available in Canada. The session will cover key scientific data that support the appropriate use of these medications medications, and will also provide an opportunity to ask questions to GSK Medical.
Download invitation

Speaker:
Dr. Robert Tautkus MD
Family Medicine
Fellow of the Canadian Society of Phlebology

 

Objectives:
1) Understand the signs, symptoms and pathophysiology of Chronic Venous Disease (CVD) in Canada
2) Understand the signs, symptoms and pathophysiology of Hemorrhoids in Canada
3) Discuss the Venoprotective and Anti-inflammatory properties of new treatments for CVD and HD

 
Download invitation

You are invited to attend an Information Session about SHINGRIX, the new non-live shingles vaccine.

Download the invitation for more information